Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

NeuroOne Medical Tech Q3 Sales $32.00K Miss $40.00K Estimate

Author: Benzinga Newsdesk | August 11, 2022 04:19pm
NeuroOne Medical Tech (NASDAQ:NMTC) reported quarterly sales of $32.00 thousand which missed the analyst consensus estimate of $40.00 thousand by 20.00 percent. This is a 20.19 percent decrease over sales of $40.10 thousand the same period last year.

Posted In: NMTC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist